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BACKGROUND: The earliest white matter changes in Huntington’s disease are seen before disease onset in the
premanifest stage around the striatum, within the corpus callosum, and in posterior white matter tracts. While
experimental evidence suggests that these changes may be related to abnormal gene transcription, we lack an
understanding of the biological processes driving this regional vulnerability.
METHODS: Here, we investigate the relationship between regional transcription in the healthy brain, using the Allen
Institute for Brain Science transcriptome atlas, and regional white matter connectivity loss at three time points over 24
months in subjects with premanifest Huntington’s disease relative to control participants. The baseline cohort
included 72 premanifest Huntington’s disease participants and 85 healthy control participants.
RESULTS: We show that loss of corticostriatal, interhemispheric, and intrahemispheric white matter connections at
baseline and over 24 months in premanifest Huntington’s disease is associated with gene expression proﬁles
enriched for synaptic genes and metabolic genes. Corticostriatal gene expression proﬁles are predominately asso-
ciated with motor, parietal, and occipital regions, while interhemispheric expression proﬁles are associated with
frontotemporal regions. We also show that genes with known abnormal transcription in human Huntington’s disease
and animal models are overrepresented in synaptic gene expression proﬁles, but not in metabolic gene expression
proﬁles.
CONCLUSIONS: These ﬁndings suggest a dual mechanism of white matter vulnerability in Huntington’s disease, in
which abnormal transcription of synaptic genes and metabolic disturbance not related to transcription may drive
white matter loss.
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https://doi.org/10.1016/j.biopsych.2017.10.019Huntington’s disease (HD) is a progressive fatal neurodegen-
erative disease caused by a CAG repeat expansion in the HTT
gene on chromosome 4. Individuals with more than 39 CAG
repeats are certain to develop HD, allowing investigation of the
premanifest stage (preHD) many years before symptom onset
(1). While the caudate and putamen show the earliest gray
matter changes (2), white matter (WM) changes are seen
around the striatum, within the corpus callosum, and in the
posterior WM tracts (2–5). We have demonstrated a hierarchy
of WM vulnerability where corticostriatal connections show
greatest changes in preHD and control participants, followed
by interhemispheric and intrahemispheric connections (6).
Voxel-based morphometry suggests (2,7) that gray matter
and WM abnormalities in the striatum occur in parallel in those
furthest from disease onset, but more recent work (5) suggests
that gray matter atrophy precedes WM atrophy in the striatum.ª 2017 Society o
N: 0006-3223However, as this was a cross-sectional study it is not yet
possible to deﬁne a typical time lag. Thus, patterns of WM loss
in preHD are well established, but the underlying pathological
processes are unclear.
Mutant huntingtin protein causes cellular dysfunction and
ultimately neuronal cell death through several processes (8,9),
including downstream effects on synaptic signaling (10),
cellular metabolism (11), mitochondrial dysfunction (12), im-
mune activation (13), and alterations in transcription (14).
Furthermore, transcription levels of genes involved in these
processes are atypical in human HD and animal models
(14,15). Decreased expression of synaptic proteins in cortical
pyramidal neurons of HD mouse models are linked to abnormal
corticostriatal connectivity (16), while changes in transcription
levels of brain-derived neurotrophic factor, another protein
involved in synaptic transmission, are associated with changesf Biological Psychiatry. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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models of HD are consistent with these ﬁndings. Reduced
brain-derived neurotrophic factor is seen in the rat striatum
after quinolinic acid injection (18), and reduced brain-derived
neurotrophic factor and nerve growth factor are seen after
3-nitropropionic acid treatment (19).
Some genes show a direct association with WM integrity.
Loss of peroxisome proliferator–activated receptor gamma
coactivator 1-alpha, involved in the transcriptional regulation of
energy metabolism, results in striatal degeneration and corpus
callosum WM abnormalities in HD mouse models (20).
Reduced transcription levels of myelin-related genes are
associated with WM abnormalities in HD mouse models (21).
Given the relationship between WM connectivity and gene
transcription in HD, here we investigated how regional gene
transcription proﬁles of the healthy human brain, obtained from
the Allen Institute for Brain Science (AIBS) human tran-
scriptome atlas (22), were associated with WM connectivity
loss in preHD. Based on association between synaptic and
metabolic genes and WM loss in HD (20,21) we hypothesized
that WM connectivity loss in preHD would be associated with




To test our hypothesis, WM connectivity loss was determined
using diffusion-weighted imaging from a longitudinal cohort of
preHD and control participants. Brains were parcellated into 70
cortical and 2 subcortical (caudate and putamen) regions of
interest (ROIs) based on the Desikan FreeSurfer atlas (23). The
caudate and putamen were chosen as these regions show the
greatest changes in preHD (2). Whole-brain tractography was
performed using these parcellations to construct WM brain
networks. We have recently published a longitudinal analysis
using this cohort (6).
For each set of connections associated with a cortical ROI,
WM connectivity loss was deﬁned as corticostriatal (connec-
tions between cortex and caudate/putamen), interhemispheric
(corticocortical connections between hemispheres), or intra-
hemispheric (corticocortical connections within the same
hemisphere) (see Figure 1). WM connectivity and rate of
change in WM connectivity over 24 months were normalized
for preHD relative to control participants for each participant.
Connectivity measures were then transformed to give atrophy
and rate of atrophy measures. The resulting atrophy score was
used in the cross-sectional analysis, while the rate of atrophy
score was used in the longitudinal analysis.
To compare regional WM loss in preHD with regional gene
expression in the healthy brain, the 70 cortical ROIs (23) were
matched to the closest AIBS ROI, and gene expression data
were averaged across RNA probes corresponding to the same
gene. ROIs with gene expression values .2 SD above the
mean or range were excluded this resulted in the inclusion of
20,737 genes across 68 cortical ROIs.
Partial least squares (PLS) regression was used to
investigate the relationship between regional gene expres-
sion and regional WM loss. PLS is a multivariate technique
used when the number of predictor variables (i.e., regional2 Biological Psychiatry - -, 2017; -:-–- www.sobp.org/journalgene expression) is much larger than the number of obser-
vations (i.e., regional WM loss). It has been used previously to
investigate the relationship between gene expression and
magnetic resonance imaging (MRI)–derived regional brain
measures in healthy volunteers (24,25). For our analysis the
predictor variable comprised a gene3 ROI matrix of 20,737 3
68, and the response variable comprised a WM loss 3 ROI
matrix: 68 3 4 for the corticostriatal analysis (68 cortical
ROIs 3 left and right caudate and putamen WM loss to each
ROI region) and 68 3 1 for the inter- and intrahemispheric
analyses (68 cortical ROIs 3 inter- and intrahemispheric WM
loss for each ROI). PLS identiﬁed components or patterns of
regional gene expression having maximum covariance with
regional WM loss, such that the ﬁrst few PLS components
provide the greatest representation of the covariance. For
each component, individual genes are assigned weights
based on their contribution to the variance explained (24).
This analysis provided a weight for each gene indicating its
contribution to WM connectivity loss for each component or
pattern. Using this information, genes were ranked according
to their PLS weight. Gene enrichment analysis was then per-
formed to identify the biological functions of genes with the
highest weights using gene ontology (GO) terms (26). Here, the
signiﬁcance of a GO term was determined based on the rank of
genes associated with that term.
Imaging Cohort
The cohort included preHD and control participants from the
Track-On HD study (27), followed up at 3 time points over 24
months at four sites (London, United Kingdom; Leiden, the
Netherlands; Paris, France; and Vancouver, British Columbia,
Canada). Baseline participants included 72 preHD and 85
control participants. For the longitudinal analysis only preHD
participants with diffusion data from all 3 time points were
included (56 preHD and 65 control participants; see
Supplemental Methods).
MRI Acquisition
T1 and diffusion-weighted images were acquired on two
different 3T MRI scanners (Philips Achieva [Philips Healthcare,
Eindhoven, The Netherlands] at Leiden and Vancouver, and
Siemens TIM Trio [Siemens Corp., Erlangen, Germany] at
London and Paris). Diffusion-weighted images were acquired
with 42 unique gradient directions (b = 1000 s/mm2; see
Supplemental Methods).
Diffusion Tractography
Whole-brain probabilistic tractography was performed using
MRtrix Version 3.0 (28). The spherical-deconvolution informed
ﬁltering of tractograms 2 algorithm (29) was used to reduce
biases. To demonstrate that our results were robust to varying
methodologies, additional cross-sectional analyses used
alternative connectome construction methodologies (see
Supplemental Methods).
Mapping Gene Expression Data to MRI Space
Gene expression microarray data were used from the AIBS
atlas (22). Maybrain software (https://github.com/rittman/
maybrain) matched centroids of MRI regions to the closest
Figure 1. Schematic illustrating subgroups of regional white matter connectivity. (A) Corticostriatal: connections between cortex and striatum (caudate and
putamen) for each cortical region of interest. (B) Interhemispheric: connections to the opposite hemisphere for each cortical region of interest. (C) Intra-
hemispheric: connections within the same hemisphere for each cortical region of interest. Light blue indicates the left hemisphere, purple indicates the right
hemisphere, dark blue indicates the caudate, and yellow indicates the putamen.
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approach and three of six permutations of AIBS brain samples
were also used to ensure that results were robust to different
combinations of AIBS subjects (see Supplemental Methods).
Statistical Analysis
PLS regression was used to investigate the association be-
tween gene transcriptome of the healthy brain and WM con-
nectivity loss in preHD. Code used to perform this analysis was
adapted from Whitaker et al. (25). Random permutations of the
gene predictor variable were also investigated to ensure that
results were not due to chance (see Supplemental Methods).
GO Enrichment Analysis
We used the GO enrichment analysis and visualization tool
(GOrilla) (http://cbl-gorilla.cs.technion.ac.il) (26) to identify GO
terms that were signiﬁcantly enriched in the target gene list.
Overlap Between Gene Proﬁles and HD-Related
Genes
To investigate similarities between gene proﬁles, we identiﬁed
the signiﬁcance of gene overlap between analyses using a
hypergeometric distribution. GO enrichment analysis was also
repeated with overlap genes removed to assess whether this
affected the resulting GO terms. Overlap between genes in top
GO terms and HD genes was also investigated.
Enrichment for HD-Related Genes
We investigated whether genes showing abnormal transcrip-
tion in human and animal models of HD were enriched greater
than chance in the ﬁrst PLS components of the corticostriatal,
interhemispheric, and intrahemispheric analyses. HD gene lists
were obtained from Langfelder et al. (30). Additionally weBinvestigated whether HD-related genes were more strongly
enriched in these gene lists than other biologically plausible
gene sets, chosen at random. Gene sets for human supra-
granular genes, oligodendrocytes, and cell cycle metabolism
were also investigated (see Supplemental Methods).
RESULTS
Gene Expression Proﬁles of the Healthy Human
Brain Explain the Variance of Regional WM
Connectivity Loss in preHD
For the majority of analyses the ﬁrst PLS component
accounted for a large percentage of the variance in regional
WM loss. We therefore focused on this component. Gene
expression data explained 66% of the variance of regional WM
connectivity loss in the corticostriatal cross-sectional analysis
and 70% in the longitudinal analysis for the ﬁrst component of
the PLS and 11% and 6%, respectively, for the second
component. For the interhemispheric analysis, gene expres-
sion explained 67% WM loss cross-sectionally and 17%
longitudinally for the ﬁrst component and 9% and 60%,
respectively, for the second component. For the intrahemi-
spheric analysis, gene expression explained 24% cross-
sectionally and 65% longitudinally for the ﬁrst component
and 47% and 11%, respectively, for the second component.
See Supplemental File 1 for the ﬁrst component PLS gene
weights for these analyses.
For each analysis the ﬁrst components of the PLS were
explored. The second components were also explored if they
accounted for a large proportion of the variance. Variances
explained by the ﬁrst component ranged between 45% and
69% for random permutations of the gene predictor matrix;
however, gene and ROI weights were very different from the
original analysis.iological Psychiatry - -, 2017; -:-–- www.sobp.org/journal 3
Table 1. Corticostriatal, Interhemispheric, and Intrahemispheric Cross-Sectional Analyses
GO Term Description p Value FDR q Value Enrichmenta Bb nc bd
PLS1 Corticostriatal Cross-Sectional
GO:0050773 Regulation of dendrite development 8.05E-07 3.03E-03 2.18 124 3150 48
GO:0050804 Modulation of chemical synaptic transmission 1.06E-06 3.19E-03 1.4 297 6419 151
GO:0031344 Regulation of cell projection organization 1.88E-06 4.06E-03 1.29 549 6375 255
GO:0044057 Regulation of system process 3.31E-06 4.98E-03 1.33 481 5795 209
GO:0030030 Cell projection organization 4.31E-06 5.41E-03 1.24 699 6498 319
PLS1 Interhemispheric Cross-Sectional
GO:0050804 Modulation of chemical synaptic transmission 1.40E-14 3.51E-11 1.74 297 5246 153
GO:0031344 Regulation of cell projection organization 1.99E-13 2.73E-10 1.64 549 3924 199
GO:0043623 Cellular protein complex assembly 7.20E-13 8.34E-10 1.65 371 4892 169
GO:0061024 Membrane organization 1.51E-11 1.19E-08 1.45 820 4221 283
GO:0030030 Cell projection organization 6.38E-11 3.85E-08 1.47 699 4281 248
PLS1 Intrahemispheric Cross-Sectional
GO:0016071 mRNA metabolic process 2.91E-33 1.12E-30 1.84 593 5085 313
GO:0006396 RNA processing 4.39E-30 1.58E-27 1.65 806 5357 402
GO:0006325 Chromatin organization 1.11E-25 3.73E-23 1.79 657 4364 289
GO:0006397 mRNA processing 4.33E-21 1.42E-18 1.78 402 5435 219
GO:0019083 Viral transcription 2.79E-20 8.77E-18 3.01 99 4044 68
Gene ontology (GO) terms for biological processes associated with top-ranking genes from the ﬁrst component of the partial least squares (PLS)
analysis. The top ﬁve most signiﬁcant GO terms are displayed for each analysis. Full tables can be found in Supplementary File 2. Redundant GO
terms and those associated with .1000 genes have been excluded.
FDR, false discovery rate; mRNA, messenger RNA.
aEnrichment = (b/n) / (B/total number of genes). See Eden et al. (26) for further details.
bTotal number of genes associated with a speciﬁc GO term.
cNumber of genes in the target set.
dNumber of genes in the intersection.
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Sectional Variation in WM Connections in preHD
Relative to Control Participants
Similar signiﬁcant GO terms were seen for the corticostriatal
and interhemispheric analyses including modulation of chem-
ical synaptic transmission, regulation of cell projection orga-
nization, and cell projection organization. We refer to these as
a synaptic proﬁle. For the intrahemispheric analysis the most
signiﬁcant GO terms included messenger RNA (mRNA) meta-
bolic process, RNA processing, and chromatin organization
(see Table 1 and Figure 2), which we refer to as a metabolic/
chromatin proﬁle. For the intrahemispheric analysis the second
component of the PLS was signiﬁcantly associated with GO
terms involved in myelination and lipid metabolism. See
Supplemental File 2 for all signiﬁcant GO terms for each
analysis.
The leave-one-out analyses showed that modulation of
chemical synaptic signaling and cell projection organization
were the most signiﬁcant GO terms for corticostriatal and
interhemispheric connections for nearly all permutations. For
intrahemispheric connections, the GO terms mRNA metabolic
process, RNA processing, and chromatin organization were
among the most signiﬁcant for all permutations. Similarly the
addition of Gaussian noise also revealed consistent results
(see Supplemental File 3). The 3 out of 6 permutation analyses
revealed similar ﬁndings across many of the 8 permutations
(see Supplemental File 4).
The use of fractional anisotropy (FA) weighting and the
thresholded scale 60 easy Lausanne atlas resulted in a change4 Biological Psychiatry - -, 2017; -:-–- www.sobp.org/journalfrom synaptic to metabolic/chromatin proﬁles for the cortico-
striatal and interhemispheric connections. For intrahemispheric
connections FA weighting revealed a consistent metabolic/
chromatin proﬁle. For the thresholded scale 60 Lausanne atlas,
intrahemispheric connections showed a synaptic proﬁle. There
was no change in proﬁles across consensus thresholds of
75% and 50%. Cross-sectional analyses using random per-
mutations of genes revealed very different GO terms at minimal
levels of signiﬁcance, suggesting that our results are not due to
chance (see Supplemental File 5).
Expression Proﬁles Associated With Longitudinal
Change in WM Connections in preHD Relative to
Control Participants
For both corticostriatal and interhemispheric analyses, longi-
tudinal change in WM was associated with GO terms involving
metabolism or chromatin organization (see Supplemental
Table S1 and Supplemental Figures S1 and S2). For intra-
hemispheric analysis, longitudinal change was associated with
GO terns involved in mitochondrial function, metabolism, and
synaptic transmission (see Supplemental Table S1 and
Supplemental Figure S3). The second component of the PLS
for the interhemispheric analysis was signiﬁcantly associated
with a range of GO terms including immune function, devel-
opment, and protein folding (see Supplemental File 2). In
summary, these results suggest that regional gene expression
proﬁles associated with loss of WM connectivity in preHD are
involved in synaptic, metabolic, and chromatin-related bio-
logical processes.
Figure 2. Signiﬁcant gene ontology (GO) terms for biological processes associated with the ﬁrst component of the partial least squares analysis are plotted
in semantic space, where similar terms are clustered together. (A) Corticostriatal cross-sectional analysis semantic similarity scatter plot. (B) Interhemispheric
cross-sectional analysis semantic similarity scatter plot. (C) Intrahemispheric cross-sectional analysis semantic similarity scatter plot. In all plots, the top ﬁve
most signiﬁcant GO terms are labeled for each analysis. Redundant GO terms and those associated with greater than 1000 genes have been excluded.
Markers are scaled based on the log10 q value for the signiﬁcance of each GO term. Large blue circles are highly signiﬁcant, while red circles are less sig-
niﬁcant (see color bar). mRNA, messenger RNA.
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Proﬁles and HD-Related Genes
A signiﬁcant overlap of 346 genes (p , .001) was found be-
tween the top genes in the corticostriatal analysis and intra-
hemispheric analyses. These were then compared with the
striatum genes showing transcriptional abnormalities in HD
humans and animal models. This revealed eight genes in
common, encoding proteins involved in cell cycle (CEP135),
axon development (NEK1), and G protein coupling (ADORA2A;
see Supplemental File 6). GO enrichment analysis with overlap
genes removed did not change the most signiﬁcant GO terms.
The GO terms modulation of chemical synaptic transmission
and mRNA metabolic process showed overlap of seven genes.
HD-related genes showed overlap of 44 genes with the GO
terms modulation of chemical synaptic transmission and 7
genes with mRNA metabolic process. The overlaps were not
greater than those expected by chance.
Dissociation of Corticostriatal, Interhemispheric,
and Intrahemispheric Gene Enrichment in the
Cortex
The next step in our analysis was to explore the spatial pattern
of each gene expression proﬁle in the brain. To determine what
brain regions were enriched with each gene expression proﬁle,
we analyzed PLS ROI weights from each analysis where higher
weights related to greater gene proﬁle enrichment (see
Supplemental File 7 for ROI weights for each analysis). Cortical
regions with the highest weights in the corticostriatal analysis
(cross-sectional) were predominantly in motor, parietal, and
occipital cortices. Conversely, cortical regions with the highest
weights in the interhemispheric analysis (cross-sectional) were
predominantly in frontal, temporal, and insular cortices.
Cortical regions with the highest weights in the intrahemi-
spheric analysis (cross-sectional) included frontal, temporal,
and occipital regions (see Supplemental Table S2 and
Figure 3). Plotting corticostriatal ROI weights against bothBinterhemispheric and intrahemispheric ROI weights revealed
dissociation in terms of regions involved, where regions
enriched in the corticostriatal analysis were distinctly
different from those enriched in the interhemispheric and
intrahemispheric analyses (see Figure 4). Cross-sectional
analyses using random permutations of ROIs revealed very
different distribution of ROI weights, suggesting that our re-
sults are not due to chance (see Supplemental Figure S5 and
Supplemental File 7).
Enrichment of Genes Showing Abnormal
Transcription in HD Is Seen in the Corticostriatal
and Interhemispheric Gene Expression Proﬁles
Our next step was to assess whether genes that show
abnormal transcription in HD, both in the cortex and in the
striatum, may be associated with WM loss. The corticostriatal
gene list was signiﬁcantly enriched for abnormal HD genes in
the striatum (p , .001) and in the cortex (p , .001). The
interhemispheric gene list was signiﬁcantly enriched for
genes in the striatum (p , .001), but not in the cortex. No
signiﬁcant enrichment was seen for the intrahemispheric
gene list (see Figure 5). To ensure that the signiﬁcance dif-
ference for the striatum gene list was not related to the size of
the gene data set we repeated the analysis using the top 25
most signiﬁcant genes based on the q value from Hodges
et al. (31). Results were consistent with the 515 gene list
showing signiﬁcant enrichment for HD genes in the striatum
for the corticostriatal (p = .019) and interhemispheric (p =
.004) analyses (see Supplementary Figure S4). Enrichment
compared against biologically plausible gene sets revealed
similar results, for both 515 and 25 striatum gene lists, with
signiﬁcant enrichment for corticostriatal (p , .001) and
interhemispheric analyses (p , .001) but not for the intra-
hemispheric analysis. This suggests that abnormal tran-
scription in HD may be associated with corticostriatal and
interhemispheric WM connectivity loss.iological Psychiatry - -, 2017; -:-–- www.sobp.org/journal 5
Figure 3. Region of interest weights for cross-
sectional partial least squares regression analyses:
(A) corticostriatal, (B) interhemispheric, and (C)
intrahemispheric. Brain regions displayed on brain
mesh. Size and color of region indicates size of re-
gion of interest weight (ranked from smallest [1] to
largest [6]). See color map.
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gene expression in HD relative to control participants and
corticostriatal WM loss, we performed correlations between
the log2 fold change in the Hodges et al. (31), Durrenberger
et al. (32), and Langfelder et al. (30) studies for the 515
striatum gene set and the PLS weights from the cross-
sectional corticostriatal analysis. This revealed negative6 Biological Psychiatry - -, 2017; -:-–- www.sobp.org/journalcorrelations between PLS weights and log2 fold change
(Hodges et al. [r = 2.23, p = 1.1 3 1027], Durrenberger et al.
[r = 2.23, p = 8.4 3 1028], Langfelder et al. [r = 20.19, p =
1.6 3 1025]; see Supplemental Figure S6). This suggests
that genes associated with corticostriatal WM loss in preHD
are also those that show reduced levels of transcription in
human HD and animal models.Figure 4. Dissociation of corticostriatal and inter-
and intrahemispheric gene enrichment in the cortex.
(A) Region of interest (ROI) weights for the ﬁrst partial
least squares (PLS) component of the cross-
sectional analysis for interhemispheric vs. cortico-
striatal. (B) ROI weights for the ﬁrst PLS component
of the longitudinal analysis for interhemispheric vs.
corticostriatal. (C) ROI weights for the ﬁrst PLS
component of the cross-sectional analysis for intra-
hemispheric vs. corticostriatal. (D) ROI weights for
the ﬁrst PLS component of the longitudinal analysis
for intrahemispheric vs. corticostriatal. Each red cir-
cle represents a cortical ROI. PLS1, ﬁrst partial least
squares component.
Figure 5. Enrichment of genes showing abnormal transcription in Huntington’s disease (HD) in the ﬁrst partial least squares (PLS) component for the cross-
sectional analyses. (A) Corticostriatal analysis, HD striatum genes. (B) Interhemispheric analysis, HD striatum genes. (C) Intrahemispheric analysis, HD striatum
genes. (D) Corticostriatal analysis, HD cortex genes. (E) Interhemispheric analysis, HD cortex genes. (F) Intrahemispheric analysis, HD cortex genes. The red
circle illustrates the mean weight (on the x axis) for the gene list of interest in the ﬁrst PLS component. The y axis represents the number of permutations of
random genes from the ﬁrst PLS component. Gene lists overexpressed in the ﬁrst PLS component have a mean greater than that of the random permutations
(red circle to the right of the permutation distribution). Rperm, random permutation mean.
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We also investigated enrichment for genes associated with the
human supragranular cortex, oligodendrocytes, and cell cycle
metabolism. The corticostriatal and interhemispheric gene lists
were signiﬁcantly enriched for human supragranular cortex
genes (corticostriatal: p = .002, interhemispheric: p = .006) and
oligodendrocyte genes (corticostriatal: p , .001, interhemi-
spheric: p , .001), but not for cell cycle metabolism genes.
Conversely, the intrahemispheric gene list was signiﬁcantly
enriched for cell cycle metabolism genes (p , .001), but not for
human supragranular or oligodendrocyte genes. This suggests
a relationship between corticostriatal WM loss and abnormal
transcription in oligodendrocytes. Additionally, abnormal
transcription in cortical supragranular genes, which are impli-
cated in long-range connectivity (33), may be linked to con-
nectivity corticostriatal and interhemispheric WM loss.
DISCUSSION
In this study, we found that regional variance in WM loss in
preHD is differentially associated with the pattern of expressionBof genes involved in synaptic, metabolic, and chromatin-related
processes in the healthy human brain. Corticostriatal and
interhemispheric WM loss is associated with synaptic genes,
whereas intrahemisphericWM loss is associatedwithmetabolic
and chromatin-related genes. There is also a distinction be-
tween gene enrichment in cortical regions, where enrichment
associated with corticostriatal connections is seen in more
posterior regions such as motor, occipital, and parietal cortices,
and gene enrichment associated with interhemispheric con-
nections, which is seen in frontal, temporal, and insular cortices.
We reveal that genes showing abnormal transcription in HD
humans and animal models are overexpressed in the ranked
gene list associated with corticostriatal and interhemispheric
WM loss but not with intrahemispheric WM connection loss.
We focus on synaptic, metabolic, and chromatin-related
genes to simplify interpretation of our results. However, spe-
ciﬁc GO terms such as DNA metabolism may relate to DNA
repair (34). DNA repair genes, such asMSH3, have been linked
to CAG instability (35), age of onset (36), and disease pro-
gression (34). The GO term mRNA metabolism may relate to
splicing of mRNA, which has also been implicated in HDiological Psychiatry - -, 2017; -:-–- www.sobp.org/journal 7
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to the generation of the pathogenic exon 1 huntingtin protein
(37). We note that further work would be needed to link these
speciﬁc gene sets directly to WM loss in HD.
Several studies have analyzed gene expression proﬁles in
both human HD and animal models. Gene expression
measured in postmortem brain samples from HD patients was
most affected in the caudate, followed by the motor cortex,
while no abnormalities were detected in the prefrontal asso-
ciation cortex (31). The GO term showing greatest signiﬁcance
for both the caudate and motor cortex was synaptic trans-
mission. Furthermore, signiﬁcance for the GO terms meta-
bolism and glucose metabolism were seen in the cortex, but
not in the caudate. These ﬁndings agree with the associations
between synaptic genes and corticostriatal WM connection
loss and metabolic genes and intrahemispheric WM connec-
tion loss that we demonstrate here.
In our previous longitudinal study, WM loss was greatest in
corticostriatal and interhemispheric connections in preHD
relative to control subjects. No group differences were seen in
intrahemispheric connections (6). The analysis presented here
is based on regional atrophy of connection subtype. Therefore,
corticostriatal and interhemispheric regional atrophy is likely to
be greater than intrahemispheric regional atrophy. Further-
more, corticostriatal and interhemispheric connections have
greater topographical lengths than intrahemispheric connec-
tions (6). Therefore, these similarities between corticostriatal
and interhemispheric connections may account for the simi-
larity between gene proﬁles.
Changes from synaptic to metabolic proﬁles in cross-
sectional versus longitudinal, streamline volume versus FA
weighting, and Desikan versus scale 60 easy Lausanne atlas
were seen for corticostriatal and interhemispheric connections.
We investigated this further, showing that common genes
highly ranked in both proﬁles. One explanation for this may be
that atrophy scores cross-sectionally will be higher than lon-
gitudinal rate of atrophy scores. Similarly, atrophy scores in the
Desikan 68-region atlas are likely to be larger than in the more
ﬁnely parcellated easy Lausanne scale 60 (110-region) atlas.
With respect to FA weighting, this metric is difﬁcult to interpret
in crossing ﬁber regions, which make up an estimated 60% to
90% of the human brain (38).
The GO categories identiﬁed contain large numbers of
genes. We therefore balance this data-driven approach by
investigating whether gene proﬁles associated with regional
WM loss in preHD are enriched for genes known to show
abnormal transcription in both human HD and animal models.
Similar GO terms such as synaptic transmission and chromatin
modiﬁcation have been associated with functional brain net-
works in healthy participants (24,39). This likely represents the
close relationship between the healthy brain network and the
perturbation of that network in neurodegeneration (40).
We acknowledge the limitations of diffusion tractography.
To address these we used both constrained spherical
deconvolution tractography, which deals more effectively with
crossing ﬁbers than the diffusion tensor or multitensor
methods (28), and the spherical-deconvolution informed
ﬁltering of tractograms 2, which has higher reproducibility and
is more representative of the underlying biology of WM con-
nections than conventional methods (41). Constrained8 Biological Psychiatry - -, 2017; -:-–- www.sobp.org/journalspherical deconvolution tractography performs well at the
acquisition protocol speciﬁcations used in this study (b =1000)
(42,43). At b = 1000, a minimum number of 28 gradient di-
rections is required (44). Therefore, the angular coverage
achieved using constrained spherical deconvolution tractog-
raphy at b = 1000 is more than sufﬁcient, with 42 directions.
The use of gene expression data from the healthy human
brain to explain WM loss in preHD is limited to the extent that
transcription in preHD may be different than that seen in
healthy brains. However, studies from postmortem manifest
HD brains show that the transcription in the striatum is most
affected, with limited abnormalities in the cortex (31). Indeed,
the transcription of only 25 genes in the cortex is abnormal in
both human and animal studies, compared with 515 in the
striatum (30). Therefore, we mitigated for the likely transcription
abnormalities in preHD by using only cortical gene expression
data from the AIBS transcriptome atlas (45).
We mapped the anatomical location of ROIs to corre-
sponding regions in the AIBS atlas. However, the resolution of
these atlases are different, and thus we acknowledge that the
correspondence may not be exact and may be a limitation of
our methodology. There are other human brain transcriptome
atlas such as Braineac (46) and the Human Brain Tran-
scriptome project (47); however, these atlases offer low reso-
lution compared with the AIBS atlas, in which only a small
number of cortical regions have been sampled, so the analysis
carried out in this study could not be reproduced using Brai-
neac or the Human Brain Transcriptome project atlas.
The utility of using information from the healthy human brain
to inform us about the patterns and mechanisms of neuro-
degeneration has been demonstrated many times in neuro-
imaging. Functional connectivity and WM networks from
healthy participants can predict atrophy in Alzheimer’s dis-
ease, corticobasal syndrome, frontotemporal dementia, and
Parkinson’s disease (41,48–50). More recently, transcriptome
data from the healthy brains of the AIBS atlas has been used to
investigate the association between the expression of
schizophrenia risk genes and WM disconnectivity (51). The
regional expression of the tau gene MAPT from the AIBS atlas
has also been linked to the selective vulnerability of highly
connected brain regions in Parkinson’s disease and progres-
sive supranuclear palsy (52).
Conclusions
We show that corticostriatal and interhemispheric WM
connection loss is associated with the expression of synaptic
genes in preHD, while intrahemispheric WM loss is associated
with metabolic genes. Genes showing abnormal transcription
in HD are associated with the synaptic proﬁles, but not with
metabolic gene proﬁles. These ﬁndings have important impli-
cations for linking the earliest WM changes in preHD to the
underlying pathological processes that may drive them.
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